A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is dominated by festivities scheduled for our shortest person, who passed another milestone on the calendar. Otherwise, we plan to indulge by reading and napping. And what about you? This remains a lovely time of year to enjoy the great outdoors — perhaps a pumpkin is in your future. It is never too soon to plan an end-of-year getaway. Or you could look ahead toward your health insurance choices for next year, or what is left of them. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Amazon (AMZN) has received approval for wholesale pharmacy licenses in at least 12 states, according to The St. Louis Post-Dispatch. These include Nevada, Arizona, North Dakota, Louisiana, Alabama, New Jersey, Michigan, Connecticut, Idaho, New Hampshire, Oregon, and Tennessee, underscoring mounting speculation the company is poised to enter the pharmacy business. Not surprisingly, the news sent shares in drugstore chains down.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy